James Tollitt

Stott Lane
Salford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Correction: Pauzaite et al. Dbf4-Cdc7 (DDK) Inhibitor PHA-767491 Displays Potent Anti-Proliferative Effects via Crosstalk with the CDK2-RB-E2F Pathway. Biomedicines 2022, 10, 2012.

Correction: Pauzaite et al. Dbf4-Cdc7 (DDK) Inhibitor PHA-767491 Displays Potent Anti-Proliferative Effects via Crosstalk with the CDK2-RB-E2F Pathway. Biomedicines 2022, 10, 2012.

Journal: Biomedicines
Published: January 28, 2026

Safety of Testosterone Therapy in Chronic Kidney Disease: A Propensity Score-Matched Cohort Study.

Safety of Testosterone Therapy in Chronic Kidney Disease: A Propensity Score-Matched Cohort Study.

Journal: The world journal of men's health
Published: October 02, 2025

Pathophysiology of cognitive impairment in chronic kidney disease.

Pathophysiology of cognitive impairment in chronic kidney disease.

Journal: Current opinion in nephrology and hypertension
Published: September 15, 2025

Impact of CKD and COPD co-existence on mortality, vascular dementia, and Alzheimer's dementia; a comparative cohort study.

Impact of CKD and COPD co-existence on mortality, vascular dementia, and Alzheimer's dementia; a comparative cohort study.

Journal: BMC nephrology
Published: March 24, 2025

Digital physical activity intervention via the Kidney BEAM platform in patients with polycystic kidney disease: a randomized controlled trial.

Digital physical activity intervention via the Kidney BEAM platform in patients with polycystic kidney disease: a randomized controlled trial.

Journal: Clinical kidney journal
Published: November 06, 2024

Identifying Research Priorities for Cognition in CKD: A Delphi Study.

Identifying Research Priorities for Cognition in CKD: A Delphi Study.

Journal: Kidney360
Published: September 04, 2024

Health outcomes in chronic kidney disease patients with cognitive impairment or dementia: a global collaborative analysis.

Health outcomes in chronic kidney disease patients with cognitive impairment or dementia: a global collaborative analysis.

Journal: Clinical kidney journal
Published: July 10, 2024

Kidney Beam-A Cost-Effective Digital Intervention to Improve Mental Health.

Kidney Beam-A Cost-Effective Digital Intervention to Improve Mental Health.

Journal: Kidney international reports
Published: May 26, 2024

IgA vasculitis nephritis-outcomes in adult-onset disease.

IgA vasculitis nephritis-outcomes in adult-onset disease.

Journal: Rheumatology (Oxford, England)
Published: October 01, 2023

The development and internal pilot trial of a digital physical activity and emotional well-being intervention (Kidney BEAM) for people with chronic kidney disease.

The development and internal pilot trial of a digital physical activity and emotional well-being intervention (Kidney BEAM) for people with chronic kidney disease.

Journal: Scientific reports
Published: September 15, 2023

The effect of a novel, digital physical activity and emotional well-being intervention on health-related quality of life in people with chronic kidney disease: trial design and baseline data from a multicentre prospective, wait-list randomised controlled trial (kidney BEAM).

The effect of a novel, digital physical activity and emotional well-being intervention on health-related quality of life in people with chronic kidney disease: trial design and baseline data from a multicentre prospective, wait-list randomised controlled trial (kidney BEAM).

Journal: BMC nephrology
Published: March 29, 2023

Dbf4-Cdc7 (DDK) Inhibitor PHA-767491 Displays Potent Anti-Proliferative Effects via Crosstalk with the CDK2-RB-E2F Pathway.

Dbf4-Cdc7 (DDK) Inhibitor PHA-767491 Displays Potent Anti-Proliferative Effects via Crosstalk with the CDK2-RB-E2F Pathway.

Journal: Biomedicines
Published: July 15, 2022
Showing 1-12 of 29

Last Updated: 09/26/2026